Healthcare provider profile · identity verified

Manish Mathur, MD

Internal Medicine · STAUNTON, IL · NPI 1598848194

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Montelukast Sodium	Montelukast Sodium	571	134
Atorvastatin Calcium	Atorvastatin Calcium	467	126
Pantoprazole Sodium	Pantoprazole Sodium	375	88
Duloxetine Hcl	Duloxetine Hcl	359	89
Levothyroxine Sodium	Levothyroxine Sodium	351	75
Losartan Potassium	Losartan Potassium	327	75
Amlodipine Besylate	Amlodipine Besylate	257	52
Famotidine	Famotidine	240	52
Omeprazole	Omeprazole	239	59
Verapamil Er	Verapamil Hcl	212	45
Escitalopram Oxalate	Escitalopram Oxalate	207	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	205	27
Lisinopril	Lisinopril	195	45
Pravastatin Sodium	Pravastatin Sodium	183	49
Gabapentin	Gabapentin	181	37
Rosuvastatin Calcium	Rosuvastatin Calcium	180	47
Metoprolol Succinate	Metoprolol Succinate	178	40
Carvedilol	Carvedilol	164	43
Hydrochlorothiazide	Hydrochlorothiazide	146	40
Allopurinol	Allopurinol	138	37
Simvastatin	Simvastatin	132	31
Furosemide	Furosemide	131	36
Spironolactone	Spironolactone	117	34
Metformin Hcl Er	Metformin Hcl	116	38
Meloxicam	Meloxicam	115	40
Tamsulosin Hcl	Tamsulosin Hcl	113	31
Lorazepam	Lorazepam	111	19
Albuterol Sulfate Hfa	Albuterol Sulfate	109	37
Tramadol Hcl	Tramadol Hcl	104	19
Atenolol	Atenolol	102	19
Ozempic	Semaglutide	96	13
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	93	20
Nortriptyline Hcl	Nortriptyline Hcl	92	19
Methylprednisolone	Methylprednisolone	91	76
Prednisone	Prednisone	91	39
Alprazolam	Alprazolam	90	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	23
Propranolol Hcl Er	Propranolol Hcl	85	20
Eliquis	Apixaban	84	23
Warfarin Sodium	Warfarin Sodium	83	13
Felodipine Er	Felodipine	81	19
Metformin Hcl	Metformin Hcl	78	20
Clopidogrel	Clopidogrel Bisulfate	72	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	15
Azithromycin	Azithromycin	70	61
Metoprolol Tartrate	Metoprolol Tartrate	68	18
Doxycycline Monohydrate	Doxycycline Monohydrate	64	56
Rybelsus	Semaglutide	64	20
Tresiba Flextouch U-100	Insulin Degludec	63	13
Buspirone Hcl	Buspirone Hcl	59	17
Telmisartan	Telmisartan	59	12
Irbesartan	Irbesartan	58	18
Potassium Chloride	Potassium Chloride	57	17
Venlafaxine Hcl Er	Venlafaxine Hcl	57	suppressed
Symbicort	Budesonide/Formoterol Fumarate	56	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	suppressed
Sertraline Hcl	Sertraline Hcl	53	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	12
Alendronate Sodium	Alendronate Sodium	51	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	22
Farxiga	Dapagliflozin Propanediol	50	suppressed
Torsemide	Torsemide	50	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Ipratropium Bromide	Ipratropium Bromide	49	suppressed
Jardiance	Empagliflozin	48	suppressed
Lovastatin	Lovastatin	46	16
Fluticasone Propionate	Fluticasone Propionate	45	16
Glimepiride	Glimepiride	44	13
Memantine Hcl	Memantine Hcl	44	11
Synthroid	Levothyroxine Sodium	43	11
Celecoxib	Celecoxib	42	suppressed
Levetiracetam	Levetiracetam	42	suppressed
Cefdinir	Cefdinir	41	34
Diclofenac Sodium	Diclofenac Sodium	40	15
Finasteride	Finasteride	38	13
Topiramate	Topiramate	38	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Estradiol	Estradiol	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	28
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	11
Ezetimibe	Ezetimibe	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Pregabalin	Pregabalin	30	12
Theophylline Er	Theophylline Anhydrous	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	22
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Trulicity	Dulaglutide	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	25	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Verapamil Sr	Verapamil Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Calcitriol	Calcitriol	18	suppressed
Baclofen	Baclofen	17	suppressed
Colchicine	Colchicine	17	suppressed
Metronidazole	Metronidazole	17	13
Naltrexone Hcl	Naltrexone Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Ketoconazole	Ketoconazole	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Haloperidol	Haloperidol	15	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	13
Trueplus Pen Needle	Pen Needle, Diabetic	15	suppressed
Clotrimazole	Clotrimazole	14	11
Fenofibrate	Fenofibrate	14	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	14	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Digoxin	Digoxin	12	suppressed
Glipizide	Glipizide	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Methotrexate	Methotrexate Sodium	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Paroxetine Er	Paroxetine Hcl	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error